Charles River Laboratories International (CRL) Short term Debt (2016 - 2022)
Charles River Laboratories International has reported Short term Debt over the past 14 years, most recently at $2.1 million for Q3 2022.
- Quarterly results put Short term Debt at $2.1 million for Q3 2022, down 8.62% from a year ago — trailing twelve months through Sep 2022 was $2.1 million (down 8.62% YoY), and the annual figure for FY2021 was $2.8 million, down 94.43%.
- Short term Debt for Q3 2022 was $2.1 million at Charles River Laboratories International, down from $2.4 million in the prior quarter.
- Over the last five years, Short term Debt for CRL hit a ceiling of $53.7 million in Q2 2020 and a floor of $2.1 million in Q3 2022.
- Median Short term Debt over the past 5 years was $31.0 million (2018), compared with a mean of $22.4 million.
- Biggest five-year swings in Short term Debt: soared 877.21% in 2019 and later crashed 94.43% in 2021.
- Charles River Laboratories International's Short term Debt stood at $31.4 million in 2018, then grew by 22.69% to $38.5 million in 2019, then soared by 30.27% to $50.2 million in 2020, then crashed by 94.43% to $2.8 million in 2021, then decreased by 25.62% to $2.1 million in 2022.
- The last three reported values for Short term Debt were $2.1 million (Q3 2022), $2.4 million (Q2 2022), and $2.6 million (Q1 2022) per Business Quant data.